Conmed (CNMD) Change in Account Payables (2010 - 2026)
Conmed (CNMD) posted Change in Account Payables of $10.5 million for Q1 2026, up 176.99% on a QoQ basis from -$13.6 million in Q4 2025, and up 243.23% year-over-year from $3.1 million in Q1 2025.
Conmed (CNMD) Change in Account Payables (2010 - 2026) Analysis & Trends
Conmed's Change in Account Payables history runs 17 years deep, the most recent figure standing at $10.5 million for Q1 2026.
- Quarterly Change in Account Payables rose 243.23% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (up 243.64% YoY) and the FY2025 annual result came in at -$9.7 million, down 166.26% from the prior year.
- Change in Account Payables was $10.5 million for Q1 2026 at Conmed, up from -$13.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $13.0 million in Q1 2024 and bottomed at -$13.6 million in Q4 2025.
- A 5-year average of $2.6 million and a median of $2.7 million in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 1858.37% — and 2025, when it plunged 2053.8%.
- Conmed's Change in Account Payables stood at -$1.2 million in 2022, then surged by 672.55% to $6.7 million in 2023, then sank by 109.41% to -$632000.0 in 2024, then plunged by 2053.8% to -$13.6 million in 2025, then jumped by 176.99% to $10.5 million in 2026.
- Business Quant data shows CNMD's Change in Account Payables at $10.5 million in Q1 2026, -$13.6 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | 10.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.48 Mn |
| Mar 31, 2026 | 10.48 Mn |
| Dec 31, 2025 | -13.61 Mn |
| Dec 31, 2025 | -13.61 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | -7.32 Mn |
| Mar 31, 2025 | -7.32 Mn |
| Dec 31, 2024 | -632,000.00 |
| Dec 31, 2024 | -632,000.00 |
| Sep 30, 2024 | 2.05 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 301,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 13.00 Mn |
| Mar 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 6.72 Mn |
| Dec 31, 2023 | 6.72 Mn |